Імуногістохімічна характеристика проліферативної активності епітеліальних та стромальних клітин поліпів дистальної товстої кишки

A. V. Husarova; M. A. Shyshkin; V. I. Salnykov

doi:10.14739/2310-1210.2026.2.342969

Authors

A. V. Husarova Zaporizhzhia State Medical and Pharmaceutical University, Ukraine https://orcid.org/0009-0009-3832-2500
M. A. Shyshkin Zaporizhzhia State Medical and Pharmaceutical University, Ukraine https://orcid.org/0000-0002-8979-8463
V. I. Salnykov Zaporizhzhia State Medical and Pharmaceutical University, Ukraine https://orcid.org/0009-0002-9199-2174

DOI:

https://doi.org/10.14739/2310-1210.2026.2.342969

Keywords:

colorectal neoplasms, colonic polyps, cell proliferation, Ki-67 antigen, immunohistochemistry

Abstract

Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide. Colonic polyps are known to be potential precursors to CRC. Evaluating cellular proliferative activity across various polyp types and normal mucosa is essential for understanding the early stages of colorectal carcinogenesis. Ki-67 expression serves as a reliable biomarker of proliferative activity.

Aim. To investigate Ki-67 expression patterns in the epithelial and stromal cells of tubular adenomas and hyperplastic polyps of the distal colon.

Materials and methods. Pathohistological and immunohistochemical (IHC) analyses were performed on biopsy specimens from 139 patients (age range: 22–81 years). The cohort included 68 patients with tubular adenomas of the distal colon, 56 with hyperplastic polyps, and 15 controls (age range: 22–72 years) with normal distal colonic mucosa.

Results. Distal colonic polyps were characterized by moderate epithelial cell proliferation (Me = 61.38 % (49.28; 70.38) for tubular adenomas; Me = 35.26 % (4.37; 45.23) for hyperplastic polyps) and low level of stromal cell proliferation (Me = 10.51 % (1.08; 15.57) for tubular adenomas; Me = 2.84 % (0.70; 5.45) for hyperplastic polyps). Direct correlations were observed between the degree of dysplasia and Ki-67 expression levels in both epithelial (γ = 0.79) and stromal cells (γ = 0.61). The spatial distribution of Ki-67-positive cells demonstrated distinct patterns: in normal mucosa and hyperplastic polyps, proliferation was primarily confined to the lower and middle thirds of the crypts. In contrast, tubular adenomas with low-grade dysplasia exhibited an even distribution, while those with high-grade dysplasia showed a predominant localization in the upper and middle thirds of the crypts.

Conclusions. The findings indicate that evaluating Ki-67 expression in both the epithelial and stromal compartments of distal colonic polyps is a valuable tool for assessing malignancy risk. This marker may serve as a supplementary pathohistological criterion for the evaluation of precancerous lesions.

Author Biographies

A. V. Husarova, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD student, Assistant at the Department of Pathological Anatomy and Forensic Medicine

M. A. Shyshkin, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, DSc, Professor of the Department of Pathological Anatomy and Forensic Medicine

V. I. Salnykov, Zaporizhzhia State Medical and Pharmaceutical University

MD, DDS, PhD, Assistant at the Department of Propaedeutic and Surgical Dentistry

References

Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini MT, et al. Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes. Curr Drug Targets. 2021;22(9):998-1009. doi: https://doi.org/10.2174/1389450121999201117115717

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. doi: https://doi.org/https://doi.org/10.3322/caac.21660

Ukrainian cancer registry statistics. [Cancer in Ukraine, 2023-2024. Incidence, mortality, prevalence and other relevant statistics]. Bulletin of National Cancer Registry of Ukraine. 2025;(26). Ukrainian. Available from: http://ncru.inf.ua/publications/BULL_26/index_e.htm

Dornblaser D, Young S, Shaukat A. Colon polyps: updates in classification and management. Curr Opin Gastroenterol. 2024;40(1):14-20. doi: https://doi.org/https://doi.org/10.1097/MOG.0000000000000988

Satorres C, García-Campos M, Bustamante-Balén M. Molecular Features of the Serrated Pathway to Colorectal Cancer: Current Knowledge and Future Directions. Gut Liver. 2021;15(1):31-43. doi: https://doi.org/https://doi.org/10.5009/gnl19402

Vaghari-Tabari M, Ferns GA, Qujeq D, Andevari AN, Sabahi Z, Moein S. Signaling, metabolism, and cancer: An important relationship for therapeutic intervention. J Cell Physiol. 2021;236(8):5512-32. doi: https://doi.org/https://doi.org/10.1002/jcp.30276

Kasprzak A. Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques. Cancers (Basel). 2023;15(18):4570. doi: https://doi.org/https://doi.org/10.3390/cancers15184570

Uxa S, Castillo-Binder P, Kohler R, Stangner K, Müller GA, Engeland K. Ki-67 gene expression. Cell Death Differ. 2021;28(12):3357-70. doi: https://doi.org/https://doi.org/10.1038/s41418-021-00823-x

Liu Q, Ran D, Wang L, Feng J, Deng W, Mei D, et al. Association between Ki67 expression and therapeutic outcome in colon cancer. Oncol Lett. 2023;25(6):272. doi: https://doi.org/https://doi.org/10.3892/ol.2023.13858

Reynolds R, Little MP, Day S, Charvat J, Blattnig S, Huff J, et al. Cancer incidence and mortality in the USA Astronaut Corps, 1959-2017. Occup Environ Med. 2021;78(12):869-75. doi: https://doi.org/https://doi.org/10.1136/oemed-2020-107143

Nayak J, Mohanty P, Lenka A, Sahoo N, Agrawala S, Panigrahi SK. Histopathological and Immunohistochemical Evaluation of CDX2 and Ki67 in Colorectal Lesions with their Expression Pattern in Different Histologic Variants, Grade, and Stage of Colorectal Carcinomas. J Microsc Ultrastruct. 2021;9(4):183-9. doi: https://doi.org/https://doi.org/10.4103/JMAU.JMAU_69_20

Mrouj K, Andrés-Sánchez N, Dubra G, Singh P, Sobecki M, Chahar D, et al. Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis. Proc Natl Acad Sci U S A. 2021;118(10):e2026507118. doi: https://doi.org/https://doi.org/10.1073/pnas.2026507118

Elsayed I, Li L, Sheahan K, Moran B, Bakheit S, Wang X. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors. Int Immunopharmacol. 2021;100:108168. doi: https://doi.org/https://doi.org/10.1016/j.intimp.2021.108168

Mezzapesa M, Losurdo G, Celiberto F, Rizzi S, d'Amati A, Piscitelli D, et al. Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis. Int J Mol Sci. 2022;23(8):4461. doi: https://doi.org/https://doi.org/10.3390/ijms23084461

Galuppini F, Fassan M, Mastracci L, Gafà R, Lo Mele M, Lazzi S, et al. The histomorphological and molecular landscape of colorectal adenomas and serrated lesions. Pathologica. 2021;113(3):218-29. doi: https://doi.org/https://doi.org/10.32074/1591-951X-270

Wang JD, Xu GS, Hu XL, Li WQ, Yao N, Han FZ, et al. The histologic features, molecular features, detection and management of serrated polyps: a review. Front Oncol. 2024;14:1356250. doi: https://doi.org/https://doi.org/10.3389/fonc.2024.1356250

Ayerden D, Tayfur M, Balci MG. Comparison of histopathological findings of the colon adenomas and adenocarcinomas with cyclin D1 and Ki-67 expression. Niger J Clin Pract. 2021;24(11):1737-41. doi: https://doi.org/https://doi.org/10.4103/njcp.njcp_68_21